Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Manitoba

$17,500.00

DNA double-strand break repair pathway choice in Rett syndrome.

EF 2022-23

Résumé
Rett syndrome (RTT) is a neurodevelopmental disorder that affects one in every 10,000-15,000 female live births worldwide, with currently no treatment options. RTT is caused by genetic mutations in the MECP2 gene, but individuals affected by the disorder can display substantial differences in disease severity. Genetic modifiers are known as genetic variants that have the potential to alter the clinical presentation and severity of a disease. A recent genetic modifier screen in a mouse model of RTT implicated genes that are involved in repairing damage to the genetic material (i.e., DNA). We, therefore, aim to investigate the role of DNA repair in RTT. First, we will use gene editing in human RTT stem cells to interrogate a gene involved in DNA repair pathway choice. These stem cells will be differentiated into neurons and used to study DNA repair outcomes and gene expression. Our second aim includes performing a genetic screen of DNA repair genes in RTT-like cells to identify additional genes that could be important RTT genetic modifiers. This information may provide insight into how DNA repair pathways are involved in altering RTT severity. This project will be conducted out of the Neuroscience Research Program Open Lab at the HSC Kleysen Institute for Advanced Medicine (KIAM), as well as with collaborators in KIAM and other institutes (e.g., CancerCare). Further, this childhood disease research project is highly relevant to the Children’s Hospital Research Institute of Manitoba (CHRIM) and Excellence in Neurodevelopment and Rehabilitation Research in Child Heath (ENRRICH). By working alongside neuroscientists, geneticists and cancer biologists, my research will therefore provide new insights into disease-related processes in a neurodevelopmental disorder.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
485966
Name
Musaphir Paris
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
DNA double-strand break repair pathway choice in Rett syndrome.
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Genomics; Neurodevelopmental Disorder; Rett Syndrome; Stem Cells
Abstract
Rett syndrome (RTT) is a neurodevelopmental disorder that affects one in every 10,000-15,000 female live births worldwide, with currently no treatment options. RTT is caused by genetic mutations in the MECP2 gene, but individuals affected by the disorder can display substantial differences in disease severity. Genetic modifiers are known as genetic variants that have the potential to alter the clinical presentation and severity of a disease. A recent genetic modifier screen in a mouse model of RTT implicated genes that are involved in repairing damage to the genetic material (i.e., DNA). We, therefore, aim to investigate the role of DNA repair in RTT. First, we will use gene editing in human RTT stem cells to interrogate a gene involved in DNA repair pathway choice. These stem cells will be differentiated into neurons and used to study DNA repair outcomes and gene expression. Our second aim includes performing a genetic screen of DNA repair genes in RTT-like cells to identify additional genes that could be important RTT genetic modifiers. This information may provide insight into how DNA repair pathways are involved in altering RTT severity. This project will be conducted out of the Neuroscience Research Program Open Lab at the HSC Kleysen Institute for Advanced Medicine (KIAM), as well as with collaborators in KIAM and other institutes (e.g., CancerCare). Further, this childhood disease research project is highly relevant to the Children’s Hospital Research Institute of Manitoba (CHRIM) and Excellence in Neurodevelopment and Rehabilitation Research in Child Heath (ENRRICH). By working alongside neuroscientists, geneticists and cancer biologists, my research will therefore provide new insights into disease-related processes in a neurodevelopmental disorder.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Musaphir, Paris
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~
University of Manitoba - $17,500 Grant (2022-23) | Canada Spends